Global DTP Vaccines Market Report 2020 - Opportunities And Strategies, Market Forecast And Trends
The global DTP vaccines market is expected to decline from $4.19 billion in 2019 to $3.94 billion in 2020 at a compound annual growth rate (CAGR) of -6.02%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $4.80 billion in 2023 at a CAGR of 6.8%.
The DTP vaccines market consists of sales of vaccines used for the treatment of diphtheria, tetanus, and pertussis (whooping cough) and related services by entities (organizations, sole traders and partnerships) that produce vaccines for diphtheria, tetanus, and pertussis (whooping cough). The different types of vaccines available for these diseases include DTaP (diphtheria, tetanus, and acellular pertussis) vaccine, DT (diphtheria and tetanus) vaccine, Tdap (combined tetanus, diphtheria and acellular pertussis) vaccine and Td (tetanus and diphtheria) vaccine. The market consists of revenue generated by the companies manufacturing DTP vaccines by the sales of these products.
Request For A Sample For The Global DTP Vaccines Market Report:
The global DTP vaccine market is further segmented based on type and geography.
By Product Type: DTaP, TD, Tdap.
By Disease: Diphtheria, Pertussis, Tetanus.
By End User: Hospitals, Clinics, Vaccination Centers.
By Geography: The global DTP vaccine market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North America DTP vaccine market accounts for the largest share in the global DTP vaccine market.
Read More On The Report For The Global DTP Vaccines Market At:
Trends In The DTP Vaccines Market
The inadequate access to vaccines in under-developed countries is expected to limit the growth of the DTP vaccines global market. In 2018, according to the World Health Organization’s global estimates, around 19.4 million infants did not had access to DTP vaccines and around 60% of these children live in under-developed and developing countries.
DTP Vaccines Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides DTP vaccine market overviews, analyzes and forecasts market size and growth for the global DTP vaccine market, DTP vaccine market share, DTP vaccine market players, DTP vaccine market segments and geographies, DTP vaccine market’s leading competitors’ revenues, profiles and market shares. The DTP vaccine market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.